True about HIT syndrome are all Except?
**Core Concept**
Heparin-Induced Thrombocytopenia (HIT) is a complex immune-mediated disorder that occurs in response to the administration of heparin, leading to the formation of antibodies against the complex of heparin and platelet factor 4 (PF4). This reaction results in the activation of platelets, leading to thrombocytopenia and a prothrombotic state.
**Why the Correct Answer is Right**
The pathophysiology of HIT involves the formation of antibodies against the PF4-heparin complex, which activates platelets through the FcγRIIa receptor. This activation triggers a series of intracellular signaling events, leading to the release of granular contents, platelet aggregation, and thrombosis. The immune response is mediated by T-cells and B-cells, which produce IgG antibodies against the PF4-heparin complex.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because HIT is not primarily caused by the direct effect of heparin on platelet function. While heparin may have some direct effects on platelet function, the primary mechanism of HIT is the immune-mediated response to the PF4-heparin complex.
**Option B:** This option is incorrect because the diagnosis of HIT is not solely based on clinical symptoms. While patients with HIT often present with thrombocytopenia, thrombosis, and a history of recent heparin exposure, laboratory testing, including the serotonin release assay (SRA) and enzyme-linked immunosorbent assay (ELISA), is also essential for diagnosis.
**Option C:** This option is incorrect because the treatment of HIT involves the immediate discontinuation of heparin and the initiation of alternative anticoagulant therapy, such as danaparoid or argatroban. While warfarin may be used as an adjunctive treatment, it should not be initiated until at least 5 days after the last dose of heparin to avoid exacerbating the thrombocytopenia.
**Option D:** This option is incorrect because the risk of HIT is not significantly increased in patients with pre-existing thrombocytopenia. However, patients with pre-existing thrombocytopenia may be at increased risk of bleeding if they develop HIT.
**Clinical Pearl / High-Yield Fact**
A key clinical pearl in the diagnosis and management of HIT is to avoid the use of low molecular weight heparin (LMWH) and fondaparinux, as these agents can also trigger an immune response and exacerbate the condition.
**Correct Answer: D.**